CASE/0749/09/25 - Roche v Neuraxpharm

Allegations regarding a Briumvi (ublituximab) promotional presentation

  • Case number
    CASE/0749/09/25
  • Complaint received
    26 September 2025
  • Status
    Breach ruled, case report pending

Case Summary